Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor

European Journal of Neurology

Volumn 17, Issue 6, 2010, Pages 879-881

  Garcia Martin E ^a   Martinez C ^b   Alonso Navarro, H ^c,d   Benito Leon J ^e,f   Puertas, I ^c   Rubio, L ^c   Lopez Alburquerque T ^g   Agundez J A G ^a   Jimenez Jimenez F J ^c,h  

^a Centre for Research on Ecological Impacts of Coastal Cities   (Australia)

^b UNIVERSITY OF EXTREMADURA   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^e HOSPITAL DE MÓSTOLES   (Spain)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^g HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^h Hospital Universitario del Sureste de Madrid   (Spain)

Author keywords

Essential tremor; Genetics; Paraoxonase 1 polymorphism; Risk factors

Indexed keywords

ARGININE; ARYLDIALKYLPHOSPHATASE 1; GLUTAMIC ACID; GLUTAMINE; LEUCINE; METHIONINE; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL TREMOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARYLDIALKYLPHOSPHATASE; ESSENTIAL TREMOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77952526258     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02914.x     Document Type: Article

References (12)

1. Alonso-Navarro H, Benito-León J, Vázquez-Rodríguez A, et al. Temblor esencial. In : Jiménez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, eds. Tratado de los trastornos del movimiento, 2nd edn ISBN 978-84-85424-76-4)
2. Cowan AW, Wians J, Sinton CM, Varley FH, Haley RW, Munford RS. Gene therapy to prevent organophosphate intoxication. Toxicol Appl Pharmacol 2001 173 : 1 6.
3. Mackness B, Mackness MI, Arrol S, et al. Serum paraoxonase (PON1)55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998 139 : 341 349. (Pubitemid 28361819)
4. Jiménez-Jiménez FJ, Alonso-Navarro H, Ortí-Pareja M. Genética de la enfermedad de Parkinson. In : Jiménez- Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, eds. Tratado de los Trastornos del Movimiento, 2nd edn (ISBN 978-84-85424-76-4).
5. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998 13 (Suppl. 3 2 23.
6. Agúndez JA, Rodriguez I, Olivera M, et al. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians. Age Ageing 1997 26 : 147 151. (Pubitemid 27241290)
7. Benito-León J, Bemejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of Central Spain. Mov Disord 2003 18 : 389 394. (Pubitemid 36527279)
8. Kucukali CI, Aydin M, Ozkok E, et al. Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population. Psychiatr Genet 2008 18 : 289 294.
9. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001 68 : 978 989. (Pubitemid 32289743)
10. Agúndez JA, Golka K, Martínez C, Selinski S, Blaszkewicz M, García-Martín E. Unraveling ambiguous NAT2 genotyping data. Clin Chem 2008 54 : 1390 1394.
11. García-Martín E, Martínez C, Alonso-Navarro H, et al. Dopamine receptor D3 (DRD3) allelic variants and risk for essential tremor. Mov Disord 2009 [Epub ahead of print].
12. Lorenz D, Klebe S, Stevanin G, et al. Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients. Eur J Hum Genet 2009 17 : 766 773.